Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
31 Patents
#281 in New York, NY
#655 in New York
#10,936 in US
#21,284 in the World
Actinium Pharmaceuticals, Limited
Forward Citations = 53
30 inventors:
New York, NY, United States of America
Actinium Pharmaceuticals, Limited
Calculating rank
% Expired Patents = 3.2
CIPO Patents = 2
EPO Patents = 7
Forward Citations = 53
Loading Chart...
Loading Chart...
30 inventors (with patents filed for the assignee):
Dale Lincoln Ludwig (8 out of 18 patents)
Josue Manuel Moreno Bermudez (6 out of 6 patents)
Kaushik J Dave (5 out of 14 patents)
4. Dragan Cicic (5 out of 5 patents)
5. Shubh D Sharma (4 out of 62 patents)
6. Richard Henkelmann (4 out of 4 patents)
7. Eva Kabai (4 out of 4 patents)
8. Mark Berger (4 out of 4 patents)
9. Andreas Turler (3 out of 3 patents)
10. Ernst Huenges (3 out of 3 patents)
11. Sandesh Seth (3 out of 3 patents)
12. Eileen Geoghegan (3 out of 3 patents)
13. Maurits W Geerlings (2 out of 2 patents)
14. Helen Kotanides (2 out of 2 patents)
15. Mary M Chen (2 out of 2 patents)
Core Competencies:
Immunodepletion
Radioimmunotherapy
Hematological Diseases
Conjugates
Radionuclides
Cancer Treatment
Anti-CD45 Antibodies
BCL-2 Inhibitor
Nanobodies
Infusion Administration
Myelodysplastic Syndromes
Therapeutic Methods
31 patents:
Company Overview
Actinium Pharmaceuticals, Limited is a biopharmaceutical company based in New York, specializing in the development of innovative therapies for cancer treatment. The company focuses on targeted radiotherapy, leveraging its proprietary technology to create treatments that aim to improve patient outcomes. Actinium's research encompasses various aspects of oncology, including the development of novel radiopharmaceuticals designed to selectively deliver radiation to cancer cells while minimizing exposure to healthy tissue.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Actinium Pharmaceuticals, Limited. Retrieved from https://idiyas.com/company/actinium-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
7 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]